Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012. AEGR has seen an increase in hedge fund sentiment in recent months.
Neurocrine Biosciences Inc (NBIX)
Market is closed
News
- First
- << Previous
- 91 - 96
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of December. AEGR has experienced an increase in enthusiasm from smart money in recent months.
Endocyte, Inc. (NASDAQ:ECYT), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH): Should You Avoid Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)?
To most stock holders, hedge funds are seen as unimportant, old financial vehicles of the past.
Aetna Inc. (AET), Rosetta Stone Inc (RST) & More: Three Stocks Near 52-Week Highs Worth Selling
Yesterday's Automatic Data Processing (NASDAQ:ADP) employment data may not have struck a chord with optimists, and North Korean tensions appear to be escalating, but that didn't stop the S&P 500 (S&P ...
Hedge Funds Aren't Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore: Keryx Biopharmaceuticals (KERX), Rigel Pharmaceuticals, Inc. (RIGL)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds' portfolio at the end of December. NBIX shareholders have witnessed a decrease in enthusiasm from smart money of late.
3 Humongous Health-Care Stocks This Week: Dendreon Corporation (DNDN), Neurocrine Biosciences, Inc. (NBIX)
As millions of Americans brace themselves for a massive blizzard, a handful of health-care stocks have been heating up the charts over the past few days.
- First
- << Previous
- 91 - 96
Billionaire Hedge Funds
